HI
DFTX

Harbour Investments’s Definium Therapeutics DFTX Stock Holding History

Harbour Investments’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.5K Buy
+556
New +$9.44K ﹤0.01% 3240
2025
Q4 		– Sell
-556
Closed -$6.55K – 3965
2025
Q3 		$6.55K Hold
556
– – ﹤0.01% 2873
2025
Q2 		$3.61K Buy
556
+200
+56% +$1.31K ﹤0.01% 2984
2025
Q1 		$2.08K Hold
356
– – ﹤0.01% 3078
2024
Q4 		$2.48K Sell
356
-100
-22% -$688 ﹤0.01% 2963
2024
Q3 		$2.6K Hold
456
– – ﹤0.01% 2849
2024
Q2 		$3.29K Buy
456
+177
+63% +$1.55K ﹤0.01% 2666
2024
Q1 		$2.62K Buy
279
+179
+179% +$1.02K ﹤0.01% 2699
2023
Q4 		$366 Buy
100
+90
+900% +$271 ﹤0.01% 2969
2023
Q3 		$31 Hold
10
– – ﹤0.01% 2958
2023
Q2 		$36 Hold
10
– – ﹤0.01% 2986
2023
Q1 		$32 Hold
10
– – ﹤0.01% 2965
2022
Q4 		$22 Buy
+10
New +$28 ﹤0.01% 2976
2021
Q4 		$0 Sell
11
-40
-78% -$1.28K ﹤0.01% 3283
2021
Q3 		$2K Sell
51
-91
-64% -$3.93K ﹤0.01% 3335
2021
Q2 		$7K Buy
+142
New +$7.45K ﹤0.01% 2915

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harbour Investments's DFTX Position: Q1 2026 in Review

Harbour Investments opened a new position in Definium Therapeutics (DFTX) in Q1 2026: 556 shares worth $10.5K. The stake represents ﹤0.01% of the portfolio and ranks #3240 among its holdings. This is a return to the name: Harbour Investments previously reported a position in DFTX as recently as Q3 2025.

Harbour Investments first reported a position in DFTX in Q2 2021 and has held it in 16 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Harbour Investments held 556 shares of Definium Therapeutics worth $10.5K as of Q1 2026.
  • Definium Therapeutics was a new Harbour Investments position in Q1 2026.
  • Definium Therapeutics made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #3240 holding.
  • Harbour Investments first reported a position in Definium Therapeutics in Q2 2021 and has held it in 16 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.